Another OX40L antibody (KY1005) examined in atopic dermatitis patients was engineered to be non-depleting, which was prudent given that this receptor is expressed in an inducible manner on a variety of cells, but the results have not been posted yet [NCT03754309]. The gene discussed is TNFSF4; the disease is atopic eczema.